Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.

Rivera, Fernando; Romero, C; Jimenez-Fonseca, P; Izquierdo-Manuel, M; Salud, A; Martínez, E; Jorge, M; Arrazubi, V; Méndez, J C; García-Alfonso, P; Reboredo, M; Barriuso, J; Muñoz-Unceta, N; Jimeno, R; López, C

Rivera, Fernando; Romero, C; Jimenez-Fonseca, P; Izquierdo-Manuel, M; Salud, A; Martínez, E; Jorge, M; Arrazubi, V; Méndez, J C; García-Alfonso, P; Reboredo, M; Barriuso, J; Muñoz-Unceta, N; Jimeno, R; López, C.

Afiliação

Rivera F; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla and Instituto de Investigación Marqués de Valdecilla (IDIVAL), Avda Valdecilla SN, 39008, Santander, Spain. Fernando.rivera@scsalud.es.
Romero C; Medical Oncology Department, POVISA, Vigo, Spain.
Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Izquierdo-Manuel M; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Salud A; Medical Oncology Department, Hospital Arnau de Vilanova, Lleida, Spain.
Martínez E; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla and Instituto de Investigación Marqués de Valdecilla (IDIVAL), Avda Valdecilla SN, 39008, Santander, Spain.
Jorge M; Medical Oncology Department, Hospital Xeral Cies, Vigo, Spain.
Arrazubi V; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
Méndez JC; Medical Oncology Department, Centro Oncológico de Galicia, Coruña, Spain.
García-Alfonso P; Medical Oncology Department, Hospital Gregorio Marañón, Madrid, Spain.
Reboredo M; Medical Oncology Department, Complejo Hospitalario de A Coruña, Coruña, Spain.
Barriuso J; Medical Oncology Department, Hospital La Paz, Madrid, Spain.
Muñoz-Unceta N; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla and Instituto de Investigación Marqués de Valdecilla (IDIVAL), Avda Valdecilla SN, 39008, Santander, Spain.
Jimeno R; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla and Instituto de Investigación Marqués de Valdecilla (IDIVAL), Avda Valdecilla SN, 39008, Santander, Spain.
López C; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla and Instituto de Investigación Marqués de Valdecilla (IDIVAL), Avda Valdecilla SN, 39008, Santander, Spain.

Cancer Chemother Pharmacol ; 84(6): 1365, 2019 Dec.

Article em En | MEDLINE | ID: mdl-31587095

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google